Trials / Unknown
UnknownNCT03754205
Vaginal CO2 Laser and the Genitourinary Syndrome of Menopause
The Clinical, Histopathological, Cytological and Microbiological Efficacy of the Micro-ablative Fractional CO2 Laser : A Double-blind Randomized Placebo-controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- National and Kapodistrian University of Athens · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Accepted
Summary
This study evaluates the clinical, histopathological, cytological and microbiological efficacy of Microablative Fractional CO2 laser intravaginally administered in postmenopausal women with Genitourinary Syndrome of Menopause. Half participants will receive active CO2 laser therapy, while the other half will receive placebo CO2 laser therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Microablative Fractional CO2 laser | 3 therapies intravaginally administered will be applied at monthly intervals |
Timeline
- Start date
- 2018-01-18
- Primary completion
- 2020-04-15
- Completion
- 2021-01-15
- First posted
- 2018-11-27
- Last updated
- 2020-01-14
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT03754205. Inclusion in this directory is not an endorsement.